| DB ID | MyCo_4425 |
| Title | Increased presepsin levels are associated with the severity of fungal bloodstream infections |
| Year | 2018 |
| PMID | 30379880 |
| Fungal Diseases involved | Fungemia |
| Associated Medical Condition | None |
| Genus | Candida |
| Species | parapsilosis |
| Organism | Candida parapsilosis |
| Ethical Statement | This study complied with the principles of the Declaration of Helsinki and the current ethical guidelines and was approved by the ethics committee of Niigata University Medical and Dental Hospital (#2015–2432). |
| Site of Infection | None |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Plasma |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | Presepsin |
| Biomarker Full Name | Presepsin |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Japan |
| Cohort | Here performed a prospective study on consecutive patients who were hospitalized for fungemia at the Niigata University Medical & Dental Hospital from April 2016 to December 2017. |
| Cohort No. | 11 |
| Age Group | 34-88 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Assay |
| Analysis Method | Invitro assay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Invitro assay |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
